Actelion, Owkin Partner on Machine Learning to Improve Clinical Trials

Actelion, Owkin Partner on Machine Learning to Improve Clinical Trials

306354

Actelion, Owkin Partner on Machine Learning to Improve Clinical Trials

A joint effort between the startup Owkin and Actelion Pharmaceuticals, one of the Janssen companies, will seek to develop machine learning techniques that could improve how clinical trials are designed, and how the results are analyzed. While the two companies will work to create tools that can be applied in trials for any disease, the first part of the project is specifically focused on pulmonary arterial hypertension (PAH). “We’re thrilled to embark on this project to…

You must be logged in to read/download the full post.